Biostage Inc (NASDAQ:BSTG) posted its earnings results on Thursday. The company reported ($0.18) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.07. The business earned $26 million during the quarter.

Biostage (NASDAQ:BSTG) opened at 0.87 on Thursday. The stock’s market capitalization is $14.88 million. The company has a 50 day moving average of $0.94 and a 200-day moving average of $1.20. Biostage has a 12-month low of $0.73 and a 12-month high of $3.47.

Earnings History for Biostage (NASDAQ:BSTG)

Separately, Maxim Group reissued a “buy” rating and issued a $3.00 target price on shares of Biostage in a report on Thursday, August 11th.

Biostage Company Profile

Biostage, Inc, formerly Harvard Apparatus Regenerative Technology, Inc, is a biotechnology company. The Company is engaged in developing bioengineered organ implants based on its Cellframe technology. Its Cellframe technology consists of a biocompatible scaffold that is seeded with the recipient’s own cells.

5 Day Chart for NASDAQ:BSTG

Receive News & Stock Ratings for Biostage Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biostage Inc and related stocks with our FREE daily email newsletter.